The defibrillator consists of two paddles, 12cm in diameter, which are placed in firm contact with the chest wall. One paddle is placed to the right of the breast bone (sternum) at the level of the ...

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

Cardioversion in atrial fibrillation (AF) is associated with an increased risk of thromboembolism. Current recommendations advise therapy with the anticoagulant warfarin both before and after ...

The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.

Hubner and colleagues in the UK have recently described a simplified cardioversion service that has significantly reduced waiting times at their center. They have introduced intravenous midazolam ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Pharmacologic cardioversion followed by electrical cardioversion and electrical cardioversion only were found to be safe and effective in patients presenting to the emergency department with recent ...

Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...

Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

Background: Several clinical factors have been studied to predict atrial fibrillation (AF) recurrence after electrical cardioversion (ECV) with limited predictive value. Methods: A method able to ...

Some patients are having their defibrillation leads taken out early due to shock coil calcification, according to an FDA alert. Boston Scientific has informed healthcare providers that device leads ...

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: ...